ZBH

Zimmer Biomet Holdings, Inc.

$107.32

-0.93%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

Source: Yahoo Finance
AI summary

Price & performance

1M+16.7%
3M+9.1%
YTD+19.6%
1Y+23.4%
52-week range—
Beta0.38
Full chart and returns against a benchmark

Q-Score

66/ 100

Quality against peers; 50 is the peer median.

Growth48
Risk78
Performance45
Valuation73
Profitability66
Leverage65
Sentiment31
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$8.2B+7.2%
Net income$705.1M-22.0%
Net margin8.6%-3.2 pts
Historical fundamentals

Revenue exposure

42%of revenue from outside the US
Americas62%
EMEA22%
Asia Pacific15%
Regions, segments, customers and suppliers

Valuation

ZBHIndustryP/E26.4729.61P/S2.373.49EV/EBITDA12.0918.38P/B1.603.39PEG——
Dividend yield0.92%
Every valuation metric

Earnings

Nov 4next report, before the open
EPS estimate$1.88
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate